Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Talaris Therapeutics, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income  -14.7-18.1-18.3-14.2-12.9-11.4-9.3-6.8
Depreciation and amortization   0.40.30.20.20.10.10.1
Stock-based compensation     1.01.1  0.6
Change in working capital   [+]   3.21.5  0.2
Other operating activities  14.70.51.70.00.10.20.10.2
Cash from operations  0.0-17.3-16.3-9.8-10.1-11.0-9.0-5.7
   
Capital expenditures  0.01.11.3-1.2-0.70.30.2-0.2
Purchases of short-term investments, net   48.040.01.92.4140.534.3-104.1
Other cash from investing   -29.2-20.9  -241.0-33.20.0
Cash from investing  0.019.920.40.71.7-100.11.3-104.4
   
Issuance of common stock, net       139.5  
Option exercises   0.00.00.20.1 0.00.0
Other cash from financing   0.10.10.6-0.5-2.00.0-0.5
Cash from financing  0.00.10.00.4-0.6137.50.0-0.5
   
Free cash flow  0.0-16.2-14.9-11.0-10.9-10.6-8.9-5.9
        Per share (diluted)  $0.00($0.39)($0.36)($0.38)($0.27)($0.39)($1.24)($0.88)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy